Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision updated: v3.4.3 added; v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government-funding notice and prior Revision: v3.4.1 from the page.
    Difference
    0.4%
    Check dated 2026-02-11T11:55:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a government funding notice about potential delays and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:27:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added metadata fields 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' and a new revision tag 'Revision: v3.4.0'; removed/renamed items include 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data', along with capitalization changes in 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:19:52.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive changes to study details, eligibility criteria, or trial outcomes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:25:06.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Introduced a top-level Locations section with California and Maryland subsections, replacing the prior California Locations and Maryland Locations headings. This clarifies where recruitment sites are listed for the study.
    Difference
    0.3%
    Check dated 2025-12-23T21:20:31.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.